Mitochondria in Cell-Based Therapy for Stroke.
Despite a relatively developed understanding of the pathophysiology underlying primary and secondary mechanisms of cell death after ischemic injury, there are few established treatments to improve stroke prognoses. A major contributor to secondary cell death is mitochondrial dysfunction. Recent advancements in cell-based therapies suggest that stem cells may be revolutionary for treating stroke, and the reestablishment of mitochondrial integrity may underlie these therapeutic benefits. In fact, functioning mitochondria are imperative for reducing oxidative damage and neuroinflammation following stroke and reperfusion injury. In this review, we will discuss the role of mitochondria in establishing the anti-oxidative effects of stem cell therapies for stroke.
Published In/Presented At
Monsour, M., Gordon, J., Lockard, G., Alayli, A., & Borlongan, C. V. (2023). Mitochondria in Cell-Based Therapy for Stroke. Antioxidants (Basel, Switzerland), 12(1), 178. https://doi.org/10.3390/antiox12010178
Medical Education | Medicine and Health Sciences
USF-LVHN SELECT Program, USF-LVHN SELECT Program Students